(A) Schematic diagram of a retrograde tracer injection performed. CAV-2-Cre or CTB647 was used in combination with Ai14 or wild-type mice, respectively. (B) An example fluorescent image of the …
Presynaptic cell numbers projecting to vCA1.
Presynaptic cell numbers projecting to vCA1.
(A) Fluorescent images of the injection site (vCA1) of CAV2-Cre (60 nl) of Ai14 mice for analysis of presynaptic neuron distribution using AMaSiNe. The presynaptic cell numbers counted in individual …
(A) Schematic diagram of injection performed and two hypothesized outcomes. Yellow color indicates double-labeled neurons. PFC: Prefrontal cortex, ACC: Anterior cingulate cortex, MC: Motor cortex, …
Single and double labeled EN cell numbers.
(A-D) Example fluorescent images of branching of vCA1-projecting neurons. All images were from the same mouse shown in Figure 2N–O. DG: Dentate gyrus.
(A) Schematic diagram of injection performed. (B) An example fluorescent image of a horizontal brain section containing an injection site in endopiriform (EN). (C) An example fluorescent image of …
Normalized GFP signals in hippocampal slices.
(A) Top: An example fluorescent image of intermediate hippocampal sections from the same brain as in Figure 3B and C. Bottom: GFP signal profile at the distal and proximal region indicated in the …
(A) Schematic diagram of injection performed for monosynaptic rabies tracing. Flox-TVA-GFP (60 nl) was injected into the vCA1. 4 wk later, Rabies-mCherry (60 nl) was injected. (B) Location of …
Number of presynaptic cells projecting to ventral hippocampal interneurons.
Recorded EN-evoked EPSPs from ventral CA1 interneurons.
(A) Example fluorescent images of starter cells in ventral CA1 (vCA1). TVA_oG-expressing neurons were labeled by GFP and rabies-expressing neurons were labeled by mCherry. GFP and mCherry …
(A) A confocal image of recorded pyramidal neurons in vCA1. Recorded pyramidal neurons were filled with biocytin and post-labeled with Alexa488. Ori.: oriens, Super.: superficial layer pyramidal …
All EPSC and IPSC amplitude in Figure 5C.
(A) Plots comparing peak amplitude of photo-evoked excitatory postsynaptic currents (EPSCs) in superficial and deep pyramidal neurons. Thin gray lines indicate paired data. Median peak amplitude; …
(A) Schematic diagram of performed. After CAV2-Cre (60 nl) injection into the ventral CA1 (vCA1), flox-TVA-mCherry (100 nl) was injected into the EN. 4 wk later, Rabies-GFP (100 nl) was injected …
Numbers of presynaptic cells projecting to ENvCA1-proj. neurons.
Number of presynaptic piriform cells projecting to ENvCA1-proj. neurons in different layers.
(A) An example fluorescent image of starter cells in endopiriform (EN). (B–D) Expanded images of the area marked by a white square in panel A. White allows indicate starter cells. (E) Example …
(A) Right and Middle: Schematic diagrams of injection and optic cannula implantation performed. CAV2-Cre (60 nl) was injected into the vCA1, and dlox-jGCaMP8s (100 nl) was injected into the …
Raw data of Figure 7E, G.
Maps of nose points (filled gray circles) and calcium events (filled red circles) in the arena. Heat maps of the same data (but cumulative time and calcium event are separated) were also shown for …
(A) Example of maps of nose points and calcium events in open field arena. All p-values in a correlation map were presented in Supplementary file 2. (B) Correlation plots of event number and …
(A) Schematic diagram of injection performed. (B) Left: An example fluorescent image showing expression of hM4Di in ENCA1-proj. neurons. Right: Expansion of areas marked by white rectangle in the …
Time in each chambers/ interaction zones during sociablity test.
Time in chambers/interaction zones during discrimination test.
Interaction time with objects during novel object recognition test.
% of freezing during each test phases of trace fear conditioning test.
(A) Frequency-current (FI) curve showing the effect of clozapine-N-oxide (CNO) on action potential number generated by current injection. Recording was made from hM4Di expressing ENvCA1-proj. …
Brain areas | Brain #1 | Brain #2 | Brain #3 | Brain #4 | Brain #5 |
---|---|---|---|---|---|
EN | 288 | 201 | 310 | 210 | 250 |
BLA | 85 | 107 | 175 | 208 | 118 |
SP (lateral) | 27 | 36 | 69 | 69 | 17 |
SP (medial) | 69 | 111 | 130 | 127 | 121 |
Sum | 469 | 455 | 684 | 614 | 506 |
Compared brain areas | p-value | |
---|---|---|
Agranular insular | AOB | 0.764 |
Agranular insular | PIR | 0.617 |
Agranular insular | ENT | 0.624 |
Agranular insular | CLA | 0.921 |
Agranular insular | EN | 0.971 |
Agranular insular | Palidum | 0.588 |
Agranular insular | Substantia innominata | 0.44 |
AOB | PIR | 0.016 |
AOB | ENT | 1 |
AOB | CLA | 1 |
AOB | EN | 0.156 |
AOB | Palidum | 1 |
AOB | Substantia innominata | 1 |
PIR | ENT | 0.008 |
PIR | CLA | 0.048 |
PIR | EN | 0.994 |
PIR | Palidum | 0.006 |
PIR | Substantia innominata | 0.003 |
ENT | CLA | 1 |
ENT | EN | 0.091 |
ENT | Palidum | 1 |
ENT | Substantia innominata | 1 |
CLA | EN | 0.317 |
CLA | Palidum | 0.999 |
CLA | Substantia innominata | 0.992 |
EN | Palidum | 0.079 |
EN | Substantia innominata | 0.043 |
Palidum | Substantia innominata | 1 |
p-values of correlation plots in Figure 7—figure supplement 1.
p-values of correlation plots in Figure 7—figure supplement 2A.